// App-Quantinova.ai

1405 : Hepatic and Metabolic Complications In Adult Patients With Acute Lymphoblastic Leukemia (ALL) Treated With Asparaginase-Containing Combination Chemotherapy: A Single Center Experience

Researchers

Presenter

  • Jason N. Barreto

Principal Investigators

  • Kristen B. McCullough

  • Candy S Peskey

  • Louis Letendre

  • William Hogan

  • Aref Al-Kali

  • Mark Litzow

  • Mrinal M. Patnaik

Medical Centers

  • Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

  • Department of Oncology, Mayo Clinic, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Coronary Artery Disease

  • Dyslipidemia

  • Hyperbilirubinemia

  • Diabetes

  • Gallbladder disease

  • Hyperglycemia

  • Pancreatitis

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

  • Fenofibrate

  • Dextrose Intravenous

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved